UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $22,149,600 | -88.6% | 1,320,000 | +5792.9% | 0.01% | – |
| Q1 2022 | $195,104,000 | -8.4% | 22,400 | 0.0% | 0.00% | – |
| Q4 2021 | $213,024,000 | -43.5% | 22,400 | 0.0% | 0.00% | – |
| Q3 2021 | $376,768,000 | +10.2% | 22,400 | 0.0% | 0.00% | – |
| Q2 2021 | $342,048,000 | -21.6% | 22,400 | 0.0% | 0.00% | – |
| Q1 2021 | $436,352,000 | +8.1% | 22,400 | 0.0% | 0.00% | – |
| Q4 2020 | $403,648,000 | -6.6% | 22,400 | 0.0% | 0.00% | – |
| Q3 2020 | $432,096,000 | -13.4% | 22,400 | +17.3% | 0.00% | – |
| Q2 2020 | $498,918,000 | +28.3% | 19,101 | -12.4% | 0.00% | – |
| Q1 2020 | $388,930,000 | -28.9% | 21,801 | +32.9% | 0.00% | – |
| Q4 2019 | $547,301,000 | +149.6% | 16,401 | +168.9% | 0.00% | – |
| Q2 2019 | $219,234,000 | -2.7% | 6,100 | 0.0% | 0.00% | – |
| Q1 2019 | $225,334,000 | – | 6,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,155,862 | $38,571,000 | 11.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 849,478 | $28,347,000 | 4.49% |
| Horton Capital Management, LLC | 108,670 | $3,626,000 | 3.53% |
| Prosight Management, LP | 217,686 | $7,264,000 | 3.19% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $98,598,000 | 2.35% |
| Phoenix Holdings Ltd. | 834,739 | $27,663,000 | 1.16% |
| SHIKIAR ASSET MANAGEMENT INC | 67,025 | $2,237,000 | 0.74% |
| MEITAV INVESTMENT HOUSE LTD | 272,063 | $9,080,000 | 0.66% |
| Clal Insurance Enterprises Holdings Ltd | 17,666 | $529,388,000 | 0.57% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $24,637,000 | 0.48% |